Late-onset doxorubicin-induced congestive heart failure in an elderly cancer survivor: A case report.

ABSTRACT:

Background

Recently, the survival rate of patients with cancer has improved annually due to advancements in cancer diagnosis and treatment technologies. Meanwhile, late-onset complications associated with cancer treatment significantly affect survival and quality of life. However, different from pediatric cancer survivors, there is no unified view on the follow-up of late complications in elderly cancer survivors. We reported a case of congestive heart failure as a late-onset complication of doxorubicin (DXR) in an elderly cancer survivor.

Case report

The patient is an 80-year-old woman with hypertension and chronic renal failure. She received six cycles of chemotherapy for Hodgkin's lymphoma that started in January 201X-2. The total dose of DXR was 300 mg/m², and

SUBMITTER: Suto H 

PROVIDER: S-EPMC10166870 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature